On February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,843 KRW | -0.27% | -2.69% | -11.82% |
1st Jan change | Capi. | |
---|---|---|
-11.82% | 50.6M | |
+0.71% | 257B | |
0.00% | 18.62B | |
+5.74% | 11.04B | |
-9.98% | 9.45B | |
+16.48% | 7.4B | |
+16.30% | 6.2B | |
+1.89% | 4.78B | |
-16.26% | 3.79B | |
-5.06% | 3.54B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical Incorporation